Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
about
Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and betaLiquiritigenin is a plant-derived highly selective estrogen receptor beta agonistTamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancerFourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancerPharmacologic management of bone-related complications and bone metastases in postmenopausal women with hormone receptor-positive breast cancerThe Effect of Menopausal Hormone Therapies on Breast Cancer: Avoiding the RiskThe discovery and development of selective estrogen receptor modulators (SERMs) for clinical practicePotential implications of adjuvant endocrine therapy for the oral health of postmenopausal women with breast cancerThe p53-estrogen receptor loop in cancerCyclopia extracts act as ERα antagonists and ERβ agonists, in vitro and in vivoProfile of V. Craig JordanStructure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cellsRheumatology: 15. OsteoporosisThe effect of clodronate and antioestrogens on bone loss associated with oestrogen withdrawal in postmenopausal women with breast cancerDevelopment of a novel molecular sensor for imaging estrogen receptor-coactivator protein-protein interactionsOspemifene for the treatment of postmenopausal vulvar and vaginal atrophy: recommendations for clinical use.Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidenceBreast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexesBazedoxifene exhibits antiestrogenic activity in animal models of tamoxifen-resistant breast cancer: implications for treatment of advanced disease.Cancer treatment-related bone disease.Tissue selective estrogen complex combinations with bazedoxifene/conjugated estrogens as a model.Hormone replacement therapy and fractures in older adults.Pharmacology and clinical applications of selective estrogen receptor modulators.Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy.Long-range transcriptional control of progesterone receptor gene expressionChronic tamoxifen use is associated with a decreased risk of intestinal metaplasia in human gastric epitheliumRaloxifene, a new selective estrogen receptor modulator.Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug.The effects of SERMs on the skeleton.Immunotherapeutic target expression on breast tumors can be amplified by hormone receptor antagonism: a novel strategy for enhancing efficacy of targeted immunotherapyEndocrine therapy for gynecological cancer.The best of both worlds - managing the cancer, saving the bone.Update on estrogens and the skeletonRaloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized ratsTamoxifen: a most unlikely pioneering medicine.Treating postmenopausal osteoporosis in women at increased risk of fracture - critical appraisal of bazedoxifene: a reviewThe molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer.The multifaceted mechanisms of estradiol and estrogen receptor signaling.Fas binding to calmodulin regulates apoptosis in osteoclasts.From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs).
P2860
Q24632806-8782E7A4-6A0A-4FE2-8040-D02A5E03B4DCQ24647962-2C80ED0D-483B-452E-94DF-4A083FD00953Q24670339-4C57A4A9-BAD0-4A0A-871C-5EA709E0559CQ24685693-43D64A9D-372B-4992-B47D-AB5EFC8F7711Q26746212-EFEF494F-E8AE-4376-AA88-FA41CFD8B13EQ26821782-EA63C547-9547-4C2A-AA79-55979880A65FQ26830744-07DFB3E4-9C6E-4446-9852-2A6164E0849AQ26863685-1FA8BD9C-EE36-41D7-9FF3-C6C105667257Q27027865-D8605ED7-E402-4E6B-9DF1-76694891910CQ27302901-6F3F2775-F822-4884-AAA6-3C1F901F12F1Q28253151-A4AAD9DD-3B7F-4768-A965-67206E8FCFA9Q28343990-02F36647-BDC3-4DC9-A0EA-7819C3347DDBQ28344803-C6F663B8-C77C-4526-AD38-118AE5472FC1Q28362960-7CB2B085-5E26-4536-8CCD-363F2FE0D6ACQ28482848-442AAE5E-9417-4238-AFAB-C67F5FCFDD3DQ30277966-43AD606E-B8AD-4C58-9807-2F413A193AC6Q30380010-EDED5134-5E0A-442B-AE82-E6DE5113B55BQ30409045-965BFEC0-E109-4B81-BBBC-7594D0035527Q30413295-A60A6F5D-38BD-47C3-8B0C-6B552CD22590Q30438185-35C45F4B-2E6C-4E36-A9FD-894A6012A4F6Q30456770-F50D88B2-6A38-43D5-A049-71DFF164257FQ32028226-DBB79E1C-4926-4875-AEF9-5ED3736025D8Q33384192-0CD0E32D-699D-4074-AEDE-915556EB7D8EQ33630784-8E36D51E-CCB6-4063-A321-151646051544Q33634238-D59990C5-0229-49AB-8368-09CB5019F9C2Q33670993-65A59404-3A92-45B1-BFC8-F60DE6220064Q33703846-0852BFB0-0664-4D47-8037-17CC66D52949Q33739214-389E53C9-5AE9-4890-A181-ADC2622DCA4BQ33757731-CBACFB5A-4955-486C-8820-0E1AA9AF0422Q33779152-1CCEED26-95B1-41FD-B8F6-BCA06FE7D38FQ33843872-1C7613B0-1AFB-43F0-986E-E22CE1B93F27Q33920055-76300A68-8AB4-484D-BA6E-7C859CEA9D05Q34031994-2C06B835-18BB-4BA6-9DFC-8E9E58FE4744Q34118797-C5B682CC-6308-4E7B-B7D9-9C34E45CDBC4Q34180688-4A3250FC-F6A5-4C3C-AB73-7E3B69C2167BQ34271979-5FAC434B-8EDA-4D15-96D5-EAA0D06466BEQ34311300-9E6512B6-1F61-46A5-8557-D9A35B6FBEFDQ34311547-DEA677AB-41A6-4F8C-B058-B859998F71DAQ34312838-2FEDA4FE-FADB-4A6F-B0A0-7D3C19E55D7FQ34315413-DAB62F6B-39EA-473F-88EB-F3A9BCAABE3C
P2860
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
description
1992 nî lūn-bûn
@nan
1992 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մարտին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
@ast
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
@en
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
@nl
type
label
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
@ast
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
@en
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
@nl
prefLabel
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
@ast
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
@en
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
@nl
P2093
P3181
P1476
Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer
@en
P2093
D L DeMets
H S Barden
P A Newcomb
P P Carbone
R B Mazess
V C Jordan
P3181
P356
10.1056/NEJM199203263261302
P407
P577
1992-03-26T00:00:00Z